2024-517756-35-00CompletedPhase 1
A study to learn about the study medicine called PF-08046032 in people with advanced cancers.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 12 Dec 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 33 (actual)
- First submitted
- 28 Jan 2025
- Start date
- 28 May 2025
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-517756-35-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 33
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Universitari Vall d'Hebron | Barcelona | Spain | Completed |
| Institut Catala D'oncologia | L'Hospitalet de Llobregat | Spain | Completed |
| Hospital Universitario Fundación Jiménez Díaz | Madrid | Spain | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.